The pharmacy aggregator in the archipelago

Operating a delivery business in the Philippines presents a unique set of geographic and regulatory challenges. With over 7,000 islands and a pharmaceutical market split between massive national chains and hyper-local independent drugstores, stock availability is often unpredictable. MedsGo enters this space not as a traditional pharmacy, but as a digital aggregator. By sitting on top of a network of physical branches and partner stores, it provides a unified interface for consumers to locate and purchase medication that might be out of stock at their nearest retail point.

Based in Mandaluyong and led by CEO Alex Goryainov, the company is part of a growing wave of vertical marketplaces in Southeast Asia. While general-purpose delivery apps have commoditized the transport of food and groceries, medicine remains a high-friction category due to the requirement for prescription validation and specialized handling. MedsGo addresses this by incorporating free teleconsultation services directly into its platform, creating a closed-loop system where a patient can consult a doctor, receive a digital prescription, and have the medicine delivered to their door.

Omnichannel infrastructure

MedsGo does not limit its presence to a single proprietary app. The company maintains an official store on Lazada, the regional e-commerce giant, and operates physical branches in districts like Greenfield, Mandaluyong. This omnichannel approach is a deliberate strategy to build consumer trust in a market where physical presence still serves as a proxy for legitimacy and regulatory compliance. The physical branches act as micro-fulfillment centers, allowing the company to promise fast delivery times that centralized warehouses could not achieve in the congested traffic of Metro Manila.

The inventory includes standard over-the-counter (OTC) drugs, but the company focuses heavily on prescription (RX) and specialty medications. These categories are higher-margin and foster greater user retention, as patients with chronic conditions require reliable, recurring access to specific brands. By aggregating inventory across its network, MedsGo reduces the likelihood of fulfillment failures, a common pain point in the local healthcare system.

Market position and funding

In July 2024, MedsGo secured Seed funding to expand its nationwide footprint. This capital injection suggests a push toward greater automation of its supply chain and an expansion into more provincial regions where the pharmacy-to-patient ratio is even lower than in the capital. Unlike traditional pharmacy chains that view digital as a secondary channel, MedsGo is built with the digital experience as the primary driver.

Competitively, the company faces a two-front battle. On one side are the incumbent retail giants who are slowly upgrading their own apps; on the other are the logistics platforms trying to verticalize their offerings. MedsGo's advantage lies in its specific focus on the healthcare workflow. By owning the teleconsultation and prescription verification step, they control the most critical part of the transaction, making them more than just a last-mile courier. As the Philippine digital economy matures, MedsGo is positioning its infrastructure to be the default choice for healthcare procurement in the region.